Trial Profile
A phase III trial of trehalose in patients with oculopharyngeal muscular dystrophy (OPMD)
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 23 Nov 2015
Price :
$35
*
At a glance
- Drugs Trehalose (Primary)
- Indications Oculopharyngeal muscular dystrophy
- Focus Registrational; Therapeutic Use
- 23 Nov 2015 New trial record
- 17 Nov 2015 According to a BioBlast Pharma media release, the company plans to initiate this trial in 2016.